Biogen Inc. (BIIB) vs Centene Corp. (CNC)
A side-by-side comparison of Biogen Inc. and Centene Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.
BIIB
Biogen Inc.
$217.15HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
CNC
Centene Corp.
$66.40HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — BIIB vs CNC
growth of $100 · dividends reinvested · last 10yBIIB -29.0% (-3.4%/yr)CNC +95.7% (+6.9%/yr)CNC compounded faster over this window
BIIB CNC
BIIB vs CNC: by the numbers
- •CNC is the larger company ($32.80B vs $32.08B market cap).
- •BIIB is profitable (8.39% net margin) while CNC runs a net loss (-2.63%).
- •CNC grew revenue faster over the past five years (10.35% vs -3.19% CAGR).
Metrics side by side
Valuation
| Metric | BIIB | CNC |
|---|---|---|
| P/E ratio | 38.43 | N/A |
| Forward P/E | 17.39 | 13.83 |
| P/S ratio | 3.23 | 0.17 |
| P/B ratio | 1.70 | 1.45 |
| FCF yield | 8.40% | 27.34% |
Profitability
| Metric | BIIB | CNC |
|---|---|---|
| Gross margin | 67.71% | 16.13% |
| Operating margin | 12.79% | -2.82% |
| Net margin | 8.39% | -2.63% |
| ROE | 4.43% | -22.60% |
| ROIC | 4.28% | -12.90% |
Growth (annualized)
| Metric | BIIB | CNC |
|---|---|---|
| Revenue CAGR (5Y) | -3.19% | 10.35% |
| EPS CAGR (5Y) | -18.67% | N/A |
| FCF CAGR (5Y) | -11.63% | -1.39% |
| Total return CAGR (5Y) | -6.40% | 1.83% |
Frequently asked
- Which has grown faster, BIIB or CNC?
- Over the past five years, CNC grew revenue faster — BIIB at a -3.19% CAGR versus CNC at 10.35%.
- Is BIIB or CNC more profitable?
- BIIB runs the higher net margin — BIIB at 8.39% versus CNC at -2.63%.
- How have BIIB and CNC total returns compared?
- Over the past 10 years, BIIB delivered -3.13% and CNC delivered 6.94% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Biogen P/E ratioBiogen ROECentene ROEBiogen operating marginCentene operating marginBiogen revenue growthCentene revenue growthBiogen free cash flowCentene free cash flow
Biogen & Centene appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.